Concepedia

Elande Baro

EB

Statistics

Publications

7

Citations

304

H-Index

7

Active since

2018

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Harvard Pilgrim Health Care

Harvard University

Brigham and Women's Hospital

Elande Baro is an author at Center for Drug Evaluation and Research specializing in medicine, clinical epidemiology, and propensity score adjustment.

Publications per year

2018–2024

7

Publications

7

Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation

David J. Graham, Elande Baro, Rongmei Zhang et al. · The American Journal of Medicine · 2019 · 144 citations

Medicine, Cardiology, Pharmacotherapy +15

Data Mining for Adverse Drug Events With a Propensity Score-matched Tree-based Scan Statistic

Shirley Wang, Judith C. Maro, Elande Baro et al. · Epidemiology · 2018 · 48 citations

Public Health, Biostatistics, Clinical Epidemiology +16

FDA Initiative for Drug Facts Label for Over-the-Counter Naloxone

Barbara R. Cohen, Karen Mahoney, Elande Baro et al. · New England Journal of Medicine · 2020 · 28 citations

Pharmacy, Pharmaceutical Policy, Pharmacology +17

Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity

Frederick L. Locke, Tanya Siddiqi, Caron A. Jacobson et al. · Blood · 2024 · 26 citations · Full text

Medicine, Hematology, Oncology +15

Electronic phenotyping of health outcomes of interest using a linked claims-electronic health record database: Findings from a machine learning pilot project

Teresa B. Gibson, Michael Nguyen, Timothy Burrell et al. · Journal of the American Medical Informatics Association · 2021 · 21 citations · Full text

Computing, Biomedical Informatics, Health Informatics +17

1–5 of 7